171 related articles for article (PubMed ID: 31668969)
1. Acute Biliary Obstruction after Transarterial Radioembolization with Yttrium-90.
Ghosn M; Mulé S; Chalaye J; Tacher V; Calderaro J; Luciani A; Amaddeo G
J Vasc Interv Radiol; 2019 Dec; 30(12):2043-2045. PubMed ID: 31668969
[No Abstract] [Full Text] [Related]
2. Benign Biliary Stricture after Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Kim HC; Joo I; Lee M; Chung JW
J Vasc Interv Radiol; 2020 Dec; 31(12):2014-2021. PubMed ID: 33168372
[TBL] [Abstract][Full Text] [Related]
3. Focus on Uniformity, Not Dose: The Folly of Yttrium-90 Transarterial Radioembolization Dose-Escalation Studies.
Nuffer Z
J Vasc Interv Radiol; 2024 Jun; 35(6):918-919. PubMed ID: 38447769
[No Abstract] [Full Text] [Related]
4. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN
Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308
[TBL] [Abstract][Full Text] [Related]
5. Coil-Assisted Temporary Vascular Occlusion to Protect Tumor-Free Territory during Transarterial Radioembolization.
Park JJ; Boas FE
J Vasc Interv Radiol; 2024 Jun; 35(6):929-931. PubMed ID: 38789206
[No Abstract] [Full Text] [Related]
6. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.
Hamoui N; Minocha J; Memon K; Sato K; Ryu R; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2013 Nov; 24(11):1743-5. PubMed ID: 24160828
[No Abstract] [Full Text] [Related]
7. Ablative Transarterial Radioembolization of a Parasitized Adrenal Artery for the Treatment of Hepatocellular Carcinoma.
Vidal LLC; Frey GT; Ritchie C; Lewis A; Paz-Fumagalli R; McKinney M; Toskich BB
J Vasc Interv Radiol; 2019 Mar; 30(3):473-476. PubMed ID: 30819498
[No Abstract] [Full Text] [Related]
8. Cholecystoduodenal fistula after yttrium-90 radioembolization.
Patel NM; Yuan J; David J
J Clin Gastroenterol; 2010 Sep; 44(8):594-5. PubMed ID: 20216427
[No Abstract] [Full Text] [Related]
9. Yttrium-90 Radioembolization for Hepatocellular Carcinoma with Portal Vein Invasion: Validation of the Milan Prognostic Score.
Bargellini I; Scalise P; Boni G; Traino CA; Bozzi E; Lorenzoni G; Crocetti L; Cioni R
J Vasc Interv Radiol; 2020 Dec; 31(12):2028-2032. PubMed ID: 33121865
[TBL] [Abstract][Full Text] [Related]
10. The Utility of Unilobar Technetium-99m Macroaggregated Albumin to Predict Pulmonary Toxicity In Bilobar Hepatocellular Carcinoma prior to Yttrium-90 Radioembolization.
Kallini JR; Gabr A; Kulik L; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1453-1456. PubMed ID: 27566430
[No Abstract] [Full Text] [Related]
11. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres.
Li MD; Chu KF; DePietro A; Wu V; Wehrenberg-Klee E; Zurkiya O; Liu RW; Ganguli S
J Vasc Interv Radiol; 2019 Mar; 30(3):314-319. PubMed ID: 30819470
[TBL] [Abstract][Full Text] [Related]
12. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.
Malone CD; Gibby W; Tsai R; Kim SK; Lancia S; Akinwande O; Ramaswamy RS
J Vasc Interv Radiol; 2020 May; 31(5):701-709. PubMed ID: 32127318
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life after Radioembolization for Hepatocellular Carcinoma Using a Digital Patient-Reported Outcome Tool.
Salem R; Hassan S; Lewandowski RJ; Grace K; Martin RCG; Sichlau MJ; Fung J; Kim E; Chao S; Rosner BI
J Vasc Interv Radiol; 2020 Feb; 31(2):311-314.e1. PubMed ID: 31732223
[TBL] [Abstract][Full Text] [Related]
15. Ruptured Hepatocellular Carcinoma following Transarterial Radioembolization.
Smith JC; Nasiri A; Fujimoto S; Volk M
J Vasc Interv Radiol; 2018 Sep; 29(9):1302-1305. PubMed ID: 30146205
[No Abstract] [Full Text] [Related]
16. Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cm.
Kim HC; Kim YJ; Lee JH; Suh KS; Chung JW
J Vasc Interv Radiol; 2019 Jan; 30(1):1-8. PubMed ID: 30293734
[TBL] [Abstract][Full Text] [Related]
17. Yttrium-90 Radioembolization for Breast Cancer Liver Metastases.
Gordon AC; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1316-1319. PubMed ID: 27566423
[No Abstract] [Full Text] [Related]
18. Introduction to Issue on Yttrium-90 Radioembolization.
Gandhi RT
Tech Vasc Interv Radiol; 2019 Jun; 22(2):41. PubMed ID: 31079708
[No Abstract] [Full Text] [Related]
19. Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
Allimant C; Kafrouni M; Delicque J; Ilonca D; Cassinotto C; Assenat E; Ursic-Bedoya J; Pageaux GP; Mariano-Goulart D; Aho S; Guiu B
J Vasc Interv Radiol; 2018 Dec; 29(12):1662-1670.e4. PubMed ID: 30217745
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.
Gabr A; Abouchaleh N; Ali R; Baker T; Caicedo J; Katariya N; Abecassis M; Riaz A; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2018 Nov; 29(11):1502-1510.e1. PubMed ID: 30268638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
